This report aims to provide a comprehensive presentation of the global market for Cancer & Tumor Profiling and Pathways, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer & Tumor Profiling and Pathways. This report contains market size and forecasts of Cancer & Tumor Profiling and Pathways in global, including the following market information:
Global Cancer & Tumor Profiling and Pathways Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer & Tumor Profiling and Pathways market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Immunoassays Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer & Tumor Profiling and Pathways include Illumina, Inc. (US), QIAGEN N.V. (Germany), NeoGenomics Laboratories, Inc. (US), HTG Molecular Diagnostics, Inc. (US) and Sysmex Corporation (Japan), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer & Tumor Profiling and Pathways companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer & Tumor Profiling and Pathways Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer & Tumor Profiling and Pathways Market Segment Percentages, by Type, 2022 (%)
- Immunoassays
- Next Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- In-Situ Hybridization (ISH)
- Microarrays
- Mass Spectrometry
- Others
Global Cancer & Tumor Profiling and Pathways Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer & Tumor Profiling and Pathways Market Segment Percentages, by Application, 2022 (%)
Global Cancer & Tumor Profiling and Pathways Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer & Tumor Profiling and Pathways Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Cancer & Tumor Profiling and Pathways revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Cancer & Tumor Profiling and Pathways revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Illumina, Inc. (US)
- QIAGEN N.V. (Germany)
- NeoGenomics Laboratories, Inc. (US)
- HTG Molecular Diagnostics, Inc. (US)
- Sysmex Corporation (Japan)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer & Tumor Profiling and Pathways, market overview.
Chapter 2: Global Cancer & Tumor Profiling and Pathways market size in revenue.
Chapter 3: Detailed analysis of Cancer & Tumor Profiling and Pathways company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer & Tumor Profiling and Pathways in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer & Tumor Profiling and Pathways Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer & Tumor Profiling and Pathways Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer & Tumor Profiling and Pathways Overall Market Size
2.1 Global Cancer & Tumor Profiling and Pathways Market Size: 2022 VS 2029
2.2 Global Cancer & Tumor Profiling and Pathways Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer & Tumor Profiling and Pathways Players in Global Market
3.2 Top Global Cancer & Tumor Profiling and Pathways Companies Ranked by Revenue
3.3 Global Cancer & Tumor Profiling and Pathways Revenue by Companies
3.4 Top 3 and Top 5 Cancer & Tumor Profiling and Pathways Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer & Tumor Profiling and Pathways Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer & Tumor Profiling and Pathways Players in Global Market
3.6.1 List of Global Tier 1 Cancer & Tumor Profiling and Pathways Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer & Tumor Profiling and Pathways Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer & Tumor Profiling and Pathways Market Size Markets, 2022 & 2029
4.1.2 Immunoassays
4.1.3 Next Generation Sequencing (NGS)
4.1.4 Polymerase Chain Reaction (PCR)
4.1.5 In-Situ Hybridization (ISH)
4.1.6 Microarrays
4.1.7 Mass Spectrometry
4.1.8 Others
4.2 By Type - Global Cancer & Tumor Profiling and Pathways Revenue & Forecasts
4.2.1 By Type - Global Cancer & Tumor Profiling and Pathways Revenue, 2018-2023
4.2.2 By Type - Global Cancer & Tumor Profiling and Pathways Revenue, 2024-2029
4.2.3 By Type - Global Cancer & Tumor Profiling and Pathways Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer & Tumor Profiling and Pathways Market Size, 2022 & 2029
5.1.2 Research
5.1.3 Clinical
5.2 By Application - Global Cancer & Tumor Profiling and Pathways Revenue & Forecasts
5.2.1 By Application - Global Cancer & Tumor Profiling and Pathways Revenue, 2018-2023
5.2.2 By Application - Global Cancer & Tumor Profiling and Pathways Revenue, 2024-2029
5.2.3 By Application - Global Cancer & Tumor Profiling and Pathways Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer & Tumor Profiling and Pathways Market Size, 2022 & 2029
6.2 By Region - Global Cancer & Tumor Profiling and Pathways Revenue & Forecasts
6.2.1 By Region - Global Cancer & Tumor Profiling and Pathways Revenue, 2018-2023
6.2.2 By Region - Global Cancer & Tumor Profiling and Pathways Revenue, 2024-2029
6.2.3 By Region - Global Cancer & Tumor Profiling and Pathways Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer & Tumor Profiling and Pathways Revenue, 2018-2029
6.3.2 US Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.3.3 Canada Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.3.4 Mexico Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer & Tumor Profiling and Pathways Revenue, 2018-2029
6.4.2 Germany Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.4.3 France Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.4.4 U.K. Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.4.5 Italy Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.4.6 Russia Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.4.7 Nordic Countries Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.4.8 Benelux Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer & Tumor Profiling and Pathways Revenue, 2018-2029
6.5.2 China Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.5.3 Japan Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.5.4 South Korea Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.5.5 Southeast Asia Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.5.6 India Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer & Tumor Profiling and Pathways Revenue, 2018-2029
6.6.2 Brazil Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.6.3 Argentina Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer & Tumor Profiling and Pathways Revenue, 2018-2029
6.7.2 Turkey Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.7.3 Israel Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
6.7.5 UAE Cancer & Tumor Profiling and Pathways Market Size, 2018-2029
7 Cancer & Tumor Profiling and Pathways Companies Profiles
7.1 Illumina, Inc. (US)
7.1.1 Illumina, Inc. (US) Company Summary
7.1.2 Illumina, Inc. (US) Business Overview
7.1.3 Illumina, Inc. (US) Cancer & Tumor Profiling and Pathways Major Product Offerings
7.1.4 Illumina, Inc. (US) Cancer & Tumor Profiling and Pathways Revenue in Global Market (2018-2023)
7.1.5 Illumina, Inc. (US) Key News & Latest Developments
7.2 QIAGEN N.V. (Germany)
7.2.1 QIAGEN N.V. (Germany) Company Summary
7.2.2 QIAGEN N.V. (Germany) Business Overview
7.2.3 QIAGEN N.V. (Germany) Cancer & Tumor Profiling and Pathways Major Product Offerings
7.2.4 QIAGEN N.V. (Germany) Cancer & Tumor Profiling and Pathways Revenue in Global Market (2018-2023)
7.2.5 QIAGEN N.V. (Germany) Key News & Latest Developments
7.3 NeoGenomics Laboratories, Inc. (US)
7.3.1 NeoGenomics Laboratories, Inc. (US) Company Summary
7.3.2 NeoGenomics Laboratories, Inc. (US) Business Overview
7.3.3 NeoGenomics Laboratories, Inc. (US) Cancer & Tumor Profiling and Pathways Major Product Offerings
7.3.4 NeoGenomics Laboratories, Inc. (US) Cancer & Tumor Profiling and Pathways Revenue in Global Market (2018-2023)
7.3.5 NeoGenomics Laboratories, Inc. (US) Key News & Latest Developments
7.4 HTG Molecular Diagnostics, Inc. (US)
7.4.1 HTG Molecular Diagnostics, Inc. (US) Company Summary
7.4.2 HTG Molecular Diagnostics, Inc. (US) Business Overview
7.4.3 HTG Molecular Diagnostics, Inc. (US) Cancer & Tumor Profiling and Pathways Major Product Offerings
7.4.4 HTG Molecular Diagnostics, Inc. (US) Cancer & Tumor Profiling and Pathways Revenue in Global Market (2018-2023)
7.4.5 HTG Molecular Diagnostics, Inc. (US) Key News & Latest Developments
7.5 Sysmex Corporation (Japan)
7.5.1 Sysmex Corporation (Japan) Company Summary
7.5.2 Sysmex Corporation (Japan) Business Overview
7.5.3 Sysmex Corporation (Japan) Cancer & Tumor Profiling and Pathways Major Product Offerings
7.5.4 Sysmex Corporation (Japan) Cancer & Tumor Profiling and Pathways Revenue in Global Market (2018-2023)
7.5.5 Sysmex Corporation (Japan) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer & Tumor Profiling and Pathways Market Opportunities & Trends in Global Market
Table 2. Cancer & Tumor Profiling and Pathways Market Drivers in Global Market
Table 3. Cancer & Tumor Profiling and Pathways Market Restraints in Global Market
Table 4. Key Players of Cancer & Tumor Profiling and Pathways in Global Market
Table 5. Top Cancer & Tumor Profiling and Pathways Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer & Tumor Profiling and Pathways Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer & Tumor Profiling and Pathways Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer & Tumor Profiling and Pathways Product Type
Table 9. List of Global Tier 1 Cancer & Tumor Profiling and Pathways Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer & Tumor Profiling and Pathways Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer & Tumor Profiling and Pathways Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer & Tumor Profiling and Pathways Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer & Tumor Profiling and Pathways Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer & Tumor Profiling and Pathways Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer & Tumor Profiling and Pathways Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer & Tumor Profiling and Pathways Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2024-2029
Table 30. Illumina, Inc. (US) Company Summary
Table 31. Illumina, Inc. (US) Cancer & Tumor Profiling and Pathways Product Offerings
Table 32. Illumina, Inc. (US) Cancer & Tumor Profiling and Pathways Revenue (US$, Mn) & (2018-2023)
Table 33. Illumina, Inc. (US) Key News & Latest Developments
Table 34. QIAGEN N.V. (Germany) Company Summary
Table 35. QIAGEN N.V. (Germany) Cancer & Tumor Profiling and Pathways Product Offerings
Table 36. QIAGEN N.V. (Germany) Cancer & Tumor Profiling and Pathways Revenue (US$, Mn) & (2018-2023)
Table 37. QIAGEN N.V. (Germany) Key News & Latest Developments
Table 38. NeoGenomics Laboratories, Inc. (US) Company Summary
Table 39. NeoGenomics Laboratories, Inc. (US) Cancer & Tumor Profiling and Pathways Product Offerings
Table 40. NeoGenomics Laboratories, Inc. (US) Cancer & Tumor Profiling and Pathways Revenue (US$, Mn) & (2018-2023)
Table 41. NeoGenomics Laboratories, Inc. (US) Key News & Latest Developments
Table 42. HTG Molecular Diagnostics, Inc. (US) Company Summary
Table 43. HTG Molecular Diagnostics, Inc. (US) Cancer & Tumor Profiling and Pathways Product Offerings
Table 44. HTG Molecular Diagnostics, Inc. (US) Cancer & Tumor Profiling and Pathways Revenue (US$, Mn) & (2018-2023)
Table 45. HTG Molecular Diagnostics, Inc. (US) Key News & Latest Developments
Table 46. Sysmex Corporation (Japan) Company Summary
Table 47. Sysmex Corporation (Japan) Cancer & Tumor Profiling and Pathways Product Offerings
Table 48. Sysmex Corporation (Japan) Cancer & Tumor Profiling and Pathways Revenue (US$, Mn) & (2018-2023)
Table 49. Sysmex Corporation (Japan) Key News & Latest Developments
List of Figures
Figure 1. Cancer & Tumor Profiling and Pathways Segment by Type in 2022
Figure 2. Cancer & Tumor Profiling and Pathways Segment by Application in 2022
Figure 3. Global Cancer & Tumor Profiling and Pathways Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer & Tumor Profiling and Pathways Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer & Tumor Profiling and Pathways Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer & Tumor Profiling and Pathways Revenue in 2022
Figure 8. By Type - Global Cancer & Tumor Profiling and Pathways Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer & Tumor Profiling and Pathways Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer & Tumor Profiling and Pathways Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer & Tumor Profiling and Pathways Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer & Tumor Profiling and Pathways Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer & Tumor Profiling and Pathways Revenue Market Share, 2018-2029
Figure 16. US Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer & Tumor Profiling and Pathways Revenue Market Share, 2018-2029
Figure 20. Germany Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer & Tumor Profiling and Pathways Revenue Market Share, 2018-2029
Figure 28. China Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer & Tumor Profiling and Pathways Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer & Tumor Profiling and Pathways Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer & Tumor Profiling and Pathways Revenue, (US$, Mn), 2018-2029
Figure 41. Illumina, Inc. (US) Cancer & Tumor Profiling and Pathways Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. QIAGEN N.V. (Germany) Cancer & Tumor Profiling and Pathways Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. NeoGenomics Laboratories, Inc. (US) Cancer & Tumor Profiling and Pathways Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. HTG Molecular Diagnostics, Inc. (US) Cancer & Tumor Profiling and Pathways Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sysmex Corporation (Japan) Cancer & Tumor Profiling and Pathways Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
